Monkey Herpes Virus May Lead to New Therapies

The study was published in the October 2002 issue of the Journal of Virology.

Kaposi's sarcoma is endemic among Mediterranean (affecting 25 to 40% of the populations of Italy, Spain, Egypt, and Greece) and sub-Sahara African populations. In the last 20 years, however, the disease has occurred most frequently in people with AIDS. Research on KSHV had been hampered by the difficulty of growing the virus in tissue culture. The monkey virus, on the other hand, can be cultivated to very high titers in tissue culture and grown in large quantities. These can be used in making recombinant viruses for testing in a rhesus macaque model.

Senior author Dr. Blossom Damania, assistant professor of microbiology and immunology at the University of North Carolina School of Medicine (Chapel Hill, USA), explained, "By developing this model, we can determine the genes that are important for virus survival, viral growth and replication, and genes that enable the virus to induce malignancies in its host. Once you have established the genes that are required to do all of these things, you can start thinking about developing drug therapies against these genes to prevent virus spread and to prevent the virus from inducing cancer in its host. At the present time, most herpes viruses cannot be cured but their outbreak can be prevented. Our research will help move us toward identifying potentially better therapies.”




Related Links:
UNC School of Medicine